TargetRx Atlas

mRNA_ID Gene Name drug_ID drug_Name Disease RNA_exp_pattern Evidence Details
ENST00000285238 ABCC3 DB00515 and DB00398 Cisplatin and Sorafenib cholangiocarcinoma down-regulated validated more...
ENST00000317775 NOS DB00515 Cisplatin renal injury up-regulated validated more...
ENST00000350051 BIRC5 DB00515 Cisplatin ovarian cancer down-regulated validated more...
ENST00000295400 TGFA DB00515 Cisplatin osteosarcoma down-regulated validated more...
ENST00000372330 MMP9 DB00515 (APRD00359) Cisplatin ovarian cancer down-regulated validated more...
ENST00000219070 MMP2 DB00515 (APRD00359) Cisplatin ovarian cancer down-regulated validated more...
ENST00000241393 CXCR4 DB00515 (APRD00359) Cisplatin ovarian cancer down-regulated validated more...
ENST00000343575 CXCL12 (SDF1) DB00515 (APRD00359) Cisplatin ovarian cancer down-regulated validated more...
ENST00000333681 BCL2 DB00515 (APRD00359) Cisplatin gastric cancer down-regulated validated more...
ENST00000269305 TP53 DB00515 (APRD00359) Cisplatin gastric cancer up-regulated validated more...
ENST00000296370 S100P DB00515 (APRD00359) Cisplatin bladder cancer up-regulated validated more...
@Copyright Harbin Medical University
　The 2nd Affiliated Hospital of Harbin Medical University
　 备案号：鲁ICP备2022025566号-3